PMID- 16461377 OWN - NLM STAT- MEDLINE DCOM- 20060801 LR - 20200930 IS - 0363-6135 (Print) IS - 0363-6135 (Linking) VI - 291 IP - 1 DP - 2006 Jul TI - Ca2+ source-dependent transcription of CRE-containing genes in vascular smooth muscle. PG - H97-105 AB - Altered Ca2+ handling has immediate physiological and long-term genomic effects on vascular smooth muscle function. Previously we showed that Ca2+ entry through voltage-dependent Ca2+ channels (VDCCs) or store-operated Ca2+ channels (SOCCs) results in phosphorylation of the Ca2+/cAMP response element (CRE)-binding protein in cerebral arteries. Here, oligonucleotide array analysis was used to determine gene transcription profiles resulting from these two Ca2+ entry pathways in human cerebrovascular smooth muscle cell cultures. Results were confirmed and expanded using quantitative RT-PCR, Western blot, and immunofluorescence. A distinct, yet overlapping, set of CRE-regulated genes was induced by VDCC activation using K+ membrane depolarization vs. SOCC activation by thapsigargin (TG). Membrane depolarization selectively induced a sustained increase in early growth response-1 (Egr-1) mRNA and protein, which were inhibited by the VDCC blocker nimodipine and the SOCC inhibitor 2-aminoethoxydiphenylborate (2-APB). TG selectively induced a sustained increase in MAPK phosphatase-1 (MKP-1) mRNA and protein, and these effects were decreased by 2-APB, but not by nimodipine. The physiological agonist ANG II also stimulated expression of Egr-1 and MKP-1. Coadministration of 2-APB prevented expression of Egr-1 and MKP-1, whereas nimodipine blocked only Egr-1 expression. TG and ANG II induced phosphorylation of ERK, which was sensitive to 2-APB and was selectively required for CRE-binding protein phosphorylation. Our findings thus indicate that Ca2+ entry through VDCCs and store-operated Ca2+ entry can differentially regulate CRE-containing genes in vascular smooth muscle and also imply that agonist-induced signals involved in modulation of gene transcription can be controlled by multiple sources of Ca2+. FAU - Pulver-Kaste, Renee A AU - Pulver-Kaste RA AD - Department of Pharmacology, Division of Neurological Surgery, University of Vermont, Burlington, VT 05405, USA. FAU - Barlow, Christy A AU - Barlow CA FAU - Bond, Jeffery AU - Bond J FAU - Watson, Anjanette AU - Watson A FAU - Penar, Paul L AU - Penar PL FAU - Tranmer, Bruce AU - Tranmer B FAU - Lounsbury, Karen M AU - Lounsbury KM LA - eng GR - 1-P20-RR-16462/RR/NCRR NIH HHS/United States GR - R01-HL-67351/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20060203 PL - United States TA - Am J Physiol Heart Circ Physiol JT - American journal of physiology. Heart and circulatory physiology JID - 100901228 RN - 0 (Calcium Channels, L-Type) RN - 0 (Cyclic AMP Response Element-Binding Protein) RN - SY7Q814VUP (Calcium) SB - IM MH - Animals MH - Calcium/*metabolism MH - Calcium Channels, L-Type/*physiology MH - Calcium Signaling/*physiology MH - Cells, Cultured MH - Cyclic AMP Response Element-Binding Protein/*physiology MH - Humans MH - Muscle, Smooth, Vascular/*physiology MH - Myocytes, Smooth Muscle/*physiology MH - Rats MH - Transcription, Genetic/*physiology EDAT- 2006/02/08 09:00 MHDA- 2006/08/02 09:00 CRDT- 2006/02/08 09:00 PHST- 2006/02/08 09:00 [pubmed] PHST- 2006/08/02 09:00 [medline] PHST- 2006/02/08 09:00 [entrez] AID - 00753.2005 [pii] AID - 10.1152/ajpheart.00753.2005 [doi] PST - ppublish SO - Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H97-105. doi: 10.1152/ajpheart.00753.2005. Epub 2006 Feb 3.